The relationship of peritumoral lymphatic vessel density, marginal adipose tissue invasion and clinicopathological parameters in breast carcinoma
Abstract
Objective: To investigate a possible association between peritumoral
lymphatic vessel density (LVD) and adipose tissue
invasion (ATI) of cancer cells at the tumor margin and their
correlation with other prognostic parameters in breast cancer,
including lymph node status.
Material and methods: Data of 75 patients with breast carcinoma
were evaluated through combination of peritumoral LVD
and ATI at the tumor margin and compared with clinicopathological
parameters. Peritumoral LVD was assessed by immunostaining
for D2-40 using the Chalkley counting method. Marginal
ATI was defined as either the presence of more than 20
cancer cells in direct contact with the adipose tissue or as the
presence of cancer cells in the adipose tissue.
Cases were evaluated concerning to patient’s age, tumor size
using the TNM staging system, histological type, histological
grade (Nottingham histological score, Elston and Ellis), lymphovascular
invasion, lymph node metastasis, estrogen receptor
(ER), progesterone receptor (PR), HER2/neu status and Ki-67.
Results: The relationship was identified between LVD and
marginal ATI but without statistical significancy (r = -0,207;
p=0,113). There was a significant correlation of the marginal
ATI with Ki-67 expression (r=0,250; p =0.03). The regression
model (all variables according to ATI) showed a significant total
effect (p <0.05), where Ki-67 was an only independent indicator
of ATI.
Conclusion: The present study suggests that adipose tissue invasion
of cancer cells at the tumor margin can be a better
predictive biologic indicator of aggressiveness than peritumoral
lymphatic vessel density in breast carcinoma.
Keywords: breast carcinoma, peritumoral lymphatic vessel density,
marginal adipose tissue invasion.
Full Text:
PDFReferences
Ran S, Volk L, Hall K, Flister MJ. Lymphangiogenesis and
lymphatic metastasis in breast cancer. Pathophysiology.
; 17: 229–251.
Nathanson SD, Zarbo RJ, Wachna DL, et al. Microvessels
that predict axillary lymph node metastases in patients with
breast cancer. Arch Surg. 2000; 135: 586-593.
El-Gohary Y. M, et al. Prognostic signifcance of intratumoral
and peritumoral lymphatic density and blood vessel density
in invasive breast carcinomas. American journal of clinical
pathology. 2008; 129: 578–586.
Mohammed R. A, Ellis I. O, Elsheikh S, Paish E. C, & Martin
S, G. Lymphatic and angiogenic characteristics in breast
cancer: morphometric analysis and prognostic implications.
Breast Cancer Res Treat. 2009; 113: 261–273.
Zhao, Y. C, et al. Peritumoral lymphangiogenesis induced by
vascular endothelial growth factor C and D promotes lymph
node metastasis in breast cancer patients. World journal of
surgical oncology. 2012; 10: 165.
van der Schaft, D. W, et al. Absence of lymphangiogenesis
in ductal breast cancer at the primary tumor site. Cancer
letters. 2007; 254: 128–136.
Acs G, Dumoff KL, Solin LJ, et al. Extensive retraction artifact
correlates with lymphatic invasion and nodal metastasis
and predicts poor outcome in early stage breast carcinoma.
Am J Surg Pathol. 2007; 31: 129-140.
Agarwal B, Saxena R, Morimiya A, et al. Lymphangiogenesis
does not occur in breast cancer. Am J Surg Pathol. 2005; 29:
-1455.
Kimijima I, Ohtake T, Sagara H, et al. Scattered fat invasion:
an indicator for poor prognosis in premenopausal, and for
positive estrogen receptor in postmenopausal breast cancer
patients. Oncology. 2000; 59: 25-30.
Arens N, Bleyl U, Hildenbrand R. HER2/neu, p53, Ki67,
and hormone receptors do not change during neoadjuvant
chemotherapy in breast cancer. 2005; 446 : 489-496.
Molino A, Micciolo R, Turazza M, Bonetti F, Piubello Q,
Bonetti A. Ki-67 immunostaining in 322 primary breast
cancers: associations with clinical and pathological variables
and prognosis. Int J Cancer. 1997; 74 (4) : 433-7.
Lu X, Gu Y, Ding Y, Song W, Mao J, Tan J. Correlation of
ER, PgR, HER-2/neu, p53, and VEGF with clinical characteristics
and prognosis in Chinese women with invasive
breast cancer. Breast J. 2008; 14 (3) : 308-10.
Saha Roy S, Vadlamudi R.K. Role of estrogen receptor signaling
in breast cancer metastasis. Int J Breast Cancer. 2012;
: 654698.
Elston CW, Ellis IO. Pathological prognostic factors in
breast cancer. I. The value of histological grade in breast cancer:
experience from a large study with long-term follow-up.
Histopathology 1991; 19 : 403-10.
deMascarel I, MacGrogan G, Debled M, Sierankowski G,
Brouste V, Mathoulin-Pelissier- S, et al. D2-40 in breast
cancer: should we detect more vascular emboli? Mod Pathol
; 22 : 216-22.
Deyarmin B1, Kane JL, Valente AL, van Laar R, Gallagher
C, Shriver CD, Ellsworth RE. Effect of ASCO/CAP guidelines
for determining ER status on molecular subtype. Ann
Surg Oncol. 2013 Jan; 20(1): 87-93.
Antonio C. Wolff, M. Elizabeth Hale Hammond, Kimberly
H. Allison, Brittany E. Harvey, Pamela B. Mangu, John
M.S. Bartlett. Human Epidermal Growth Factor Receptor
Testing in Breast Cancer: American Society of Clinical
Oncology/College of American Pathologists Clinical Practice
Guideline Focused Update. J Clin Oncol. 2018 July; 36
(20): 2105-2122.
Hansen S, Sørensen FB, Vach W, Grabau DA, Bak M, Rose
C. Microvessel density compared with the Chalkley count in
a prognostic study of angiogenesis in breast cancer patients.
Histopathology. 2004 May; 44(5): 428-36.
Dhakal HP1, Bassarova A, Naume B, Synnestvedt M, Borgen
E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky
KE, Nesland JM. Breast carcinoma vascularity: a comparison
of manual microvessel count and Chalkley count. Histol
Histopathol. 2009 Aug; 24(8): 1049-59. doi: 10.14670/
HH-24.1049.
Yamaguchi J, Ohtani H, Nakamura K, Shimokawa I, Kanematsu
T. Prognostic impact of marginal adipose tissue invasion
in ductal carcinoma of the breast. Am J Clin Pathol
; 130(3): 382–388.
Kuba S, Ohtani H, Yamaguchi J, et al. Incomplete inside-out
growth pattern in invasive breast carcinoma: association with
lymph vessel invasion and recurrence-free survival. Virchows
Arch 2011; 458(2): 159–169.
Moriuchi H, Yamaguchi J, Hayashi H, Ohtani H, Shimokawa
I, Abiru H, Okada H, Eguchi S. Cancer Cell Interaction
with Adipose Tissue: Correlation with the Finding of
Spiculation at Mammography. Radiology. 2016 Apr; 279(1):
-64.
Donegan WL. Tumor-related prognostic factors for breast
cancer. CA Cancer J Clin. 1997; 47: 28-51.
Zhang S, Yi S, Zhang D, et al. Intratumoral and peritumoral
lymphatic vessel density both correlate with lymph node
metastasis in breast cancer. Nature. January 2017; 7: 40364,
DOI: 10.1038/srep40364.
Scholzen T, Gerdes J. The Ki-67 protein: from the known
and the unknown. J Cell Physiol. 2000; 182 (3) : 311-22 .
Kermani T. A, Kermani I. A, Faham Z. et al. Ki-67 status in
patients with primary breast cancer and its relationship with
other prognostic factors. Biomedical Research and Therapy
; 6(2): 2986-2991.
Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF,
Ellis IO. Prognostic markers in triple-negative breast cancer.
Cancer 2007; 109(1): 25–32.
Iyengar P, Espina V, Williams TW, et al. Adipocyte-derived
collagen VI affects early mammary tumor progression in
vivo, demonstrating a critical interaction in the tumor/ stroma
microenvironment. J Clin Invest 2005; 115(5): 1163–
Refbacks
- There are currently no refbacks.